510(k) K163479
K163479 is an FDA 510(k) premarket notification submitted by KANEKA Corporation for the device "R2P Metacross RX". The FDA issued a decision of Substantially Equivalent on Jan 11, 2017. The device falls under product code LIT (Catheter, Angioplasty, Peripheral, Transluminal), a Class II device regulated under 21 CFR 870.1250. KANEKA Corporation has 9 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Jan 11, 2017
- Date Received
- Dec 12, 2016
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Catheter, Angioplasty, Peripheral, Transluminal
- Device Class
- Class II
- Regulation Number
- 870.1250
- Review Panel
- CV
- Submission Type
- 510(k)